Anionic- and lipophilic-mediated surface binding inhibitors of human leukocyte elastase

被引:16
作者
Regan, J
McGarry, D
Bruno, J
Green, D
Newman, J
Hsu, CY
Kline, J
Barton, J
Travis, J
Choi, YM
Volz, F
Pauls, H
Harrison, R
Zilberstein, A
BenSasson, SA
Chang, M
机构
[1] RHONE POULENC RORER, DEPT MED CHEM, COLLEGEVILLE, PA 19426 USA
[2] RHONE POULENC RORER, DEPT INFLAMMAT BIOL, COLLEGEVILLE, PA 19426 USA
[3] HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT EXPT MED & CANC RES, JERUSALEM, ISRAEL
关键词
D O I
10.1021/jm970251r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the synthesis of a series of diphenylmethane-based oligomers containing anionic and lipophilic functionalities that are potent inhibitors of human leukocyte elastase (HLE). The enzyme inhibition is regulated by the size of the oligomer, as well as, the number of charges. Lipophilicity is an important element in determining potency and specificity against other basic enzymes. Compounds whose scaffolds contain three phenoxyacetic acid groups and three alkyl ethers are competitive and specific inhibitors of HLE with K-i 20 nM. The mechanism of action of this class of compounds is believed to involve multidendate interactions with the surface of HLE near the active site which prevents substrate access to the catalytic site.
引用
收藏
页码:3408 / 3422
页数:15
相关论文
共 70 条
[32]   Design, synthesis, and in vitro inhibitory activity toward human leukocyte elastase, cathepsin G, and proteinase 3 of saccharin-derived sulfones and congeners [J].
Groutas, WC ;
Epp, JB ;
Venkataraman, R ;
Kuang, RZ ;
Truong, TM ;
McClenahan, JJ ;
Prakash, O .
BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (09) :1393-1400
[33]   THE DESIGN OF POTENT AND STABLE BENZISOTHIAZOLONE INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE [J].
HLASTA, DJ ;
BELL, MR ;
COURT, JJ ;
CUNDY, KC ;
DESAI, RC ;
FERGUSON, EW ;
GORDON, RJ ;
KUMAR, V ;
MAYCOCK, AL ;
SUBRAMANYAM, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (04) :331-336
[34]  
HORI H, 1985, PEPTIDES STRUCTURE F, P819
[35]   IDENTIFICATION OF 2 HYDROPHOBIC PATCHES IN THE ACTIVE-SITE CAVITY OF HUMAN CARBONIC-ANHYDRASE-II BY SOLUTION-PHASE AND SOLID-STATE STUDIES AND THEIR USE IN THE DEVELOPMENT OF TIGHT-BINDING INHIBITOR [J].
JAIN, A ;
WHITESIDES, GM ;
ALEXANDER, RS ;
CHRISTIANSON, DW .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (13) :2100-2105
[36]   INHIBITION OF HUMAN NEUTROPHIL ELASTASE AND CATHEPSIN-G BY A BIPHENYL DISULFONIC ACID COPOLYMER [J].
JANUSZ, MJ ;
HARE, M .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (08) :623-632
[37]   SYNTHESIS OF NOVEL SULFENAMIDE-CONTAINING BETA-LACTAMS [J].
JASYS, VJ ;
KELLOGG, MS ;
VOLKMANN, RA .
TETRAHEDRON LETTERS, 1991, 32 (31) :3771-3774
[38]   ONO-5046, A NOVEL INHIBITOR OF HUMAN NEUTROPHIL ELASTASE [J].
KAWABATA, K ;
SUZUKI, M ;
SUGITANI, M ;
IMAKI, K ;
TODA, M ;
MIYAMOTO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (02) :814-820
[39]  
KENNEDY AJ, 1987, EUR J RESPIR DIS, V71, P472
[40]   MECHANISM-BASED ISOCOUMARIN INHIBITORS FOR HUMAN-LEUKOCYTE ELASTASE - EFFECT OF THE 7-AMINO SUBSTITUENT AND 3-ALKOXY GROUP IN 3-ALKOXY-7-AMINO-4-CHLOROISOCOUMARINS ON INHIBITORY POTENCY [J].
KERRIGAN, JE ;
OLEKSYSZYN, J ;
KAM, CM ;
SELZLER, J ;
POWERS, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (03) :544-552